SEQUENTIELLE BEHANDLUNG GEGEN KREBS

Patent europeic · EP3432901 · En vigur

Inscripziun en il register

Numer da publicaziun: EP3432901
Numer da la dumonda: EP17770887
Gener: Patent europeic cun effect per la Svizra ed il Liechtenstein
Status: En vigur
Scrittira da patent: Concedì
Annunzià: 20-03-2017
Publitgà: 30-01-2019
Concedì: 01-09-2021
La protecziun finescha il pli tard: 19-03-2037
Proxima taxa annuala scadenta: 31-03-2027
Classas IPC: A61K 35/768 (2015.01)
A61K 31/175 (2006.01)
A61K 31/495 (2006.01)
A61K 45/06 (2006.01)
A61P 35/00 (2006.01)
Prioritad: US 201662310874 P 21.03.2016
Dumonda PCT: PCT/US2017/023148 20.03.2017
Publicaziun PCT: WO2017/165266 28.09.2017
Lingua da l’annunzia: englais
Funtauna: Swissreg

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

01-04-2026
Midada
Published in Swissreg on 01.04.2026
01-04-2025
Midada
Published in Swissreg on 01.04.2025
02-04-2024
Midada
Published in Swissreg on 02.04.2024
09-05-2023
Adressa midada
Representative
Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel → VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern
Published in Swissreg on 09.05.2023
01-04-2023
Midada
Published in Swissreg on 01.04.2023
13-07-2022
Midada
Published in Swissreg on 13.07.2022
29-10-2021
Represchentant inscrit
Representative
Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel
Published in Swissreg on 29.10.2021
01-09-2021
Concedì
Published in Swissreg on 01.09.2021

2812 Erwin Road Suite 1200 Box 90083, Durham, North Carolina 27705, US

VALIPAT

3013 Bern